市場調查報告書
商品編碼
1347593
糖尿病護理設備市場:2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測Diabetes Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球糖尿病護理設備市場規模達到296億美元。展望未來,IMARC Group預計到2028年市場規模將達到473億美元,2023-2028年年複合成長率(CAGR)為7.9%。
糖尿病護理設備是指用於監測或確定血糖水平的設備。智慧胰島素筆、血糖儀、酮、連續血糖監測儀 (CGM)、胰島素泵和糖尿病管理應用程式是一些常見的糖尿病護理設備。它們由刺血針、葡萄糖感測器、監視器、擴展塢、測試插頭和測試條組成,有助於持續監測糖尿病狀況。糖尿病護理設備廣泛用於診斷和監測糖尿病,這是一種影響血液中葡萄糖吸收量的慢性疾病。因此,這些設備有助於準確識別血糖水平,確定糖尿病治療的有效性,並降低高血糖和低血糖的發生率。
糖尿病患病率不斷上升,特別是在全球範圍內穩步成長的老年人口中,正在為市場創造積極的前景。糖尿病護理設備被廣泛用於治療和管理與該疾病相關的症狀和併發症,例如呼吸問題、腎衰竭和肝衰竭以及心血管疾病。與此相一致的是,為了更好地護理和管理疾病而廣泛使用血糖監測和胰島素輸送設備有利於市場成長。除此之外,整合人工智慧(AI)、機器學習(ML)和物聯網(IoT)的智慧糖尿病設備的推出,可以遠程監控患者的症狀和生物標記,這也為市場成長提供了動力。此外,對自我血糖監測(SMBG)的需求不斷成長,其中包括有關患者動態血糖概況的資訊,這對市場成長產生了積極影響。閱讀進一步有助於適當安排食物、活動和藥物,從而使它們成為治療糖尿病的有價值的工具。其他因素,包括廣泛的研發(R&D)活動、不斷變化的飲食習慣和久坐的生活方式,以及旨在提供更好健康服務的各種政府舉措的實施,預計將推動市場成長。
The global diabetes care devices market size reached US$ 29.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028.
Diabetes care devices refer to equipment used to monitor or determine blood sugar levels. Smart insulin pens, glucometers, ketone, continuous glucose monitors (CGMs), insulin pumps and diabetes management applications are some of the common diabetes care devices. They consist of lancets, glucose sensors, monitors, docking stations, test plugs and test strips that help constantly monitor diabetic conditions. Diabetes care devices are widely used to diagnose and monitor diabetes mellitus, a chronic disorder that affects the amount of glucose absorption in the blood. Consequently, these devices assist in accurately identifying blood sugar levels, determining the effectiveness of diabetes treatment, and lowering the instances of hyperglycemia and hypoglycemia.
The growing prevalence of diabetes, especially amongst the steadily rising geriatric population across the globe, is creating a positive outlook for the market. Diabetes care devices are widely adopted to treat and manage symptoms and complications associated with the disorder, such as respiratory issues, kidney and liver failure, and cardiovascular conditions. In line with this, the extensive utilization of glucose monitoring and insulin delivery devices for better care and management of the disease is favoring the market growth. Apart from this, the introduction of smart diabetes devices integrated with artificial intelligence (AI), machine learning (ML) and the Internet of Things (IoT) to enable remote monitoring of the patient's symptoms and biomarkers are providing an impetus to the market growth. Additionally, the increasing demand for self-monitoring of blood glucose (SMBG) that includes information regarding the patient's dynamic blood glucose profile is positively impacting the market growth. The reading further aids in the appropriate scheduling of food, activity, and medication, thus making them a valueable tool in the treatment of diabetes mellitus. Other factors, including extensive research and development (R&D) activities, evolving eating habits and sedentary lifestyles, and the implementation of various government initiatives focusing on providing better health services are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetes care devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and end user.
Blood Glucose Monitoring (BGM) Devices
Self-Monitoring Devices
Continuous Glucose Monitoring Devices
Insulin Delivery Devices
Pumps
Pens
Syringes
Jet Injectors
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others
Hospitals
Homecare
Diagnostic Centers
Ambulatory Surgery Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, ACON Laboratories Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton Dickinson and Company, Bionime Corporation, Dexcom Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sinocare Inc. and Terumo Corporation.